Lycera, a biopharmaceutical company engaged in discovering and developing novel oral medicines to treat high unmet-need autoimmune diseases, has got license to Dotmatics' entire Informatics suite including their own note book.
Dotmatics is a provider of informatics tools and scientific data management solutions to the international pharmaceutical and biotechnology industries.
Dotmatics CEO Stephen Gallagher said they have enjoyed an excellent working relationship with Lycera for the past couple of years, and they are very pleased that they can now provide them with their Informatics cloud and DBA solution.
Lycera Chemistry and Chemical Biology vice president Peter Toogood said they have found the Dotmatics database suite of software to be an extremely effective environment for sharing and analysing data.
"The adoption of these solutions from Dotmatics constitutes an integral component of our research strategy," Toogood said.